Dimitris Voliotis

Insider Reports History

Location
New York, NY
Signature
/s/ Melissa B. Epperly, Attorney-in-Fact for Dimitris Voliotis
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dimitris Voliotis:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. SVP, Clinical Development Stock Option (Right to Buy) 24,234 $1,158,385 $47.80 10 Feb 2022 Direct
Zentalis Pharmaceuticals, Inc. SVP, Clinical Development Common Stock 15,978 $164,407 $10.29 14 Feb 2022 Direct

Insider Reports Filed by Dimitris Voliotis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZNTL Zentalis Pharmaceuticals, Inc. 10 Feb 2022 4 -$30,188 4 SVP, Clinical Development 14 Feb 2022, 20:10
ZNTL Zentalis Pharmaceuticals, Inc. 18 Jan 2022 15 -$1,300,745 4 SVP, Clinical Development 20 Jan 2022, 18:15